Read next
Clinical Data Points to Broader Systemic Benefits of GLP-1 Agonists
Phase III trial results indicate GLP-1 receptor agonists reduce cardiovascular risks independently of primary weight loss outcomes, altering…
Clinical Trials Accelerate Integration of Synthetic Control Arms
Pharmaceutical firms are leveraging historical patient datasets to construct synthetic control arms, significantly reducing phase II clinical trial…
Clinical AI Integration Accelerates Radiology Diagnostics While Facing Regulatory Hurdles
Hospitals are adopting machine learning diagnostic platforms to address severe radiologist shortages, despite evolving FDA oversight standards.
Personalised Medicine Is Real in a Few Places
Treatment tailored to individual biology works well in oncology and pharmacogenomics. Elsewhere it remains mostly aspiration.
Clinical Trials Integrate Wearable Sensor Data to Accelerate Drug Approval
Pharmaceutical developers are leveraging continuous patient monitoring to improve trial retention and data fidelity.
Continuous Glucose Monitors Expand Beyond Diabetes Management
Medical device manufacturers secure regulatory approvals to offer continuous monitoring hardware to non-diabetic populations.